Novanta Inc.
NOVTTechnologyNASDAQScientific & Technical Instruments
Scan Results
Daily timeframePart of the technology sector, Novanta Inc. (NOVT) is listed under Scientific & Technical Instruments. With a market capitalization of $5.30B, it sits in mid-cap territory. The company operates Automation Enabling Technologies and Medical Solutions segments.
Market Cap
$5.30B
Beta
1.68
P/E (TTM)
106.99
P/E (Fwd)
35.89
EPS (TTM)
$1.39
EPS (Fwd)
$4.14
ROE
5.2%
ROA
4.6%
Cash
$388.8M
Total Debt
$291.3M
Free CF
$87.3M
52W Change
20.9%
Annual Financials
Cash vs Debt
Novanta Inc. holds $388.8M in cash against $291.3M in total debt, giving it a net cash position. This means the company could theoretically pay off all its debt and still have cash remaining. Free cash flow comes in at $87.3M, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. ROE of 5.2% points to modest capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. ROA of 4.6% is on the lower side, which is common in asset-heavy industries. Revenue has grown from $706.8M (2021) to $980.6M (2025), reflecting a 39% increase over the period.
A beta of 1.68 means NOVT is more volatile than average. Investors should be prepared for wider price swings relative to broader indices. The elevated P/E ratio means the stock is priced for significant future growth. If earnings disappoint, the price correction could be sharp. No single metric tells the full story. Reviewing NOVT's risk profile alongside its fundamentals and technical indicators provides a more complete picture.